Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Fenofibrate 160mg
DRUG
3 trials
Sponsors
Chong Kun Dang Pharmaceutical
, Tanta University
, Damanhour University
Conditions
Breast Cancer
Inflammatory Bowel Diseases
Mixed Hyperlipidemia
Phase 2
Fenofibrate in Ulcerative Colitis
Completed
NCT05753267
Tanta University
Inflammatory Bowel Diseases
Start: 2023-02-28
End: 2025-09-20
Updated: 2026-05-04
Phase 3
Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
NCT01956201
Chong Kun Dang Pharmaceutical
Mixed Hyperlipidemia
Start: 2013-12-31
End: 2016-08-31
Target: 476
Updated: 2015-02-04
Unknown Phase
Fenofibrate Role in Breast Cancer Patients
Completed
NCT05813145
Damanhour University
Breast Cancer
Start: 2023-01-01
End: 2024-08-05
Updated: 2025-07-08
Related Papers
Therapeutic Modulation of IL-6/STAT-3 and Nitric Oxide by Fenofibrate in Patients With Ulcerative Colitis: A Randomized Controlled Pilot Study.
2025-12-02